May 14, 2009 — Lamotrigine (Lamictal, GlaxoSmithKline) orally disintegrating tablets (ODT) have been approved by the US Food and Drug Administration (FDA) for maintenance treatment of bipolar 1 ...
Feb. 18, 2004 — Lamotrigine (LTG) is better than placebo or lithium for preventing depressive relapses in bipolar disorder, according to a presentation at the International Congress of Biological ...
LOS ANGELES -- The FDA's warning about arrhythmia risk with lamotrigine (Lamictal) based on in vitro data wasn't borne out in observational cohorts of people with epilepsy, although the risk did ...
Lamotrigine 2mg, 5mg, 25mg; blackcurrant flavor. Maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients ...
The FDA has approved Lamictal ODT (lamotrigine, from GlaxoSmithKline) orally disintegrating tablets. This approval was based on the demonstrated bioequivalence of Lamicatal ODT to Lamictal tablets.
As many as half of people with chronic psychiatric disorders such as bipolar disorder (BD) don’t consistently take their prescribed medications. The consequences—an increased risk of suicide, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results